semaglutide nejm weight loss New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) https://nej.md/444aW7f Cagrilintide–Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) https://nej.md/4ehQwLk Semaglutide in Adults with Type

Many medical weight loss centers offer this service, and several are conveniently located throughout the region

I prescribe semaglutide which is the exact same medication as Wegovy and Ozempic without the added marketing and research costs. He said he works with a pharmacy in Florida called Hallandale that he trusts and said that in this time that were in, when Novo Nordisk has such a short supply of Ozempic and Wegovy, it is absolutely 100% safe to prescribe a compounded semaglutide as long as the physician is confident in the compounding pharmacy. And whether or not hed have a patient do bloodwork prior to receiving a prescription, Colantonio said that, requiring labs depends on whether the patient has a serious medical issuethings like diabetes and bone marrow, issues like red blood cell issues, white blood cell issues, any serious kidney or liver malfunction, if they have any pancreas issues, if they have any malignancies

Evidence on Outcomes After Switching Prospective randomized data specifically on semaglutide-to-tirzepatide switching are limited as of mid-2025

Oxidized semaglutide may have reduced receptor binding affinity, meaning it is less effective at activating the GLP-1 receptor

In food-induced glucose-intolerant and prediabetic cynomolgus monkeys, oral administration of RGT-075 improved glucose tolerance and reduced food intake and fasting glucose levels